Executive Summary
This one-day snapshot reveals $6B in high-value federal grants dominated by a $1.35B HHS vaccine facility contract to Seqirus and $628M in future DHS border wall obligations to Barnard and Spencer, signaling renewed border infrastructure priority. IT/services firms like CACI ($1.14B across two contracts), Oracle, and Peraton capture 25%+ of value with multi-year stability through 2026-2030. Long-term commitments (e.g., to 2034) provide revenue visibility but flag execution risks from low outlays (avg. ~40% disbursed) and firm-fixed-price structures.
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from January 27, 2026.
Investment Signals(4)
- Border wall revival with $628M DHS commitments(HIGH)▲
Barnard ($369M) and Spencer ($259M) secure future awards dated 2026-01-27 for Rio Grande Valley barriers, indicating policy-driven infrastructure acceleration.
- $1.35B Seqirus vaccine facility sustains health manufacturing(HIGH)▲
HHS BARDA's long-term (to 2029/2034) contract with $442M outlayed and $861M options underscores federal biopharma capacity buildout.
- CACI IT dominance with $1.14B across DHS/GSA(HIGH)▲
Two contracts totaling $920M+$215M obligation provide 5-7 year revenue through 2026, with strong execution ($136M+$ negative outlay adjustments).
- DOE/VA health-IT convergence at $775M+(MEDIUM)▲
Hanford lab ops ($475M, 84% outlayed), Oracle EHRM ($300M), and Medline supplies ($74M) highlight sustained remediation and VA modernization spending.
Risk Flags(3)
- Execution[HIGH RISK]▼
Low aggregate outlays (~40% of $6B obligated) across 12 contracts with $0 disbursed, plus future 2026 award dates on $700M+ border/DHS work.
- Execution[MEDIUM RISK]▼
Firm-fixed-price on 9 contracts ($2B+ value) exposes to overruns over extended periods (avg. 5+ years to 2026-2034).
- Market[MEDIUM RISK]▼
High subawards (e.g., $391M CACI, $78M Accenture) dilute prime margins; geopolitical exposure in USAID Ukraine R&D.
Opportunities(3)
- ◆
$1.7B+ unexercised options across top contracts (e.g., Seqirus $861M, Raytheon $322M ceiling, SwRI $102M).
- ◆
Border/DHS construction surge ($628M) and GSA/DOE building projects ($780M+) amid infrastructure push.
- ◆
NASA R&D extensions (GE $179M near-complete, SwRI Lucy to 2034) with high outlays signal stable aerospace funding.
Sector Themes(3)
- ◆
11 contracts worth $2.3B (38% total) through 2026-2030 emphasize systems design (NAICS 541512) for DHS, VA, IRS, NOAA.
- ◆
$1.6B in construction/security (border wall, labs, facilities) with DHS/GSA leads, extending 3-20 years.
- ◆
$1.8B HHS/VA/DOE for vaccines, EHRM, remediation signals decade-long commitments.
Watch List(3)
- 👁
{"entity"=>"Seqirus Inc", "reason"=>"Largest single award ($1.35B, 23% total value) with $861M options and 2034 upside.", "trigger"=>"option exercises or extension beyond 2029"}
- 👁
{"entity"=>"Barnard/Spencer Construction", "reason"=>"$628M future border obligations (11% total) on 2026-01-27 awards with $0 outlay.", "trigger"=>"funding release or cancellation post-award"}
- 👁
{"entity"=>"CACI International", "reason"=>"Dual $1.14B wins (19% total) in IT with strong GSA/DHS ties.", "trigger"=>"additional BPA calls or outlay normalization"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 19 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC